Literature DB >> 23474378

Different clinical expression of patients with ankylosing spondylitis according to gender in relation to time since onset of disease. Data from REGISPONSER.

Rafaela Ortega Castro1, Pilar Font Ugalde, M Carmen Castro Villegas, Jerusalén Calvo Gutiérrez, Elisa Muñoz Gomariz, Pedro Zarco Montejo, Raquel Almodóvar, Juan Mulero Mendoza, Juan Carlos Torre-Alonso, Jordi Gratacós Masmitjá, Xavier Juanola Roura, Rafael Ariza Ariza, Pilar Fernández Dapica, Luis Francisco Linares Ferrando, M Elia Brito Brito, Eduardo Cuende Quintana, Carlos Vázquez Galeano, Manuel José Moreno Ramos, Eugenio Giménez Úbeda, José Carlos Rodríguez Lozano, Manuel Fernández Prada, Rubén Queiro Silva, Estefanía Moreno Ruzafa, Enrique Júdez Navarro, Antonio Juan Más, Cristina Medrano Le Quement, Enrique Ornilla, Carlos Montilla Morales, Manuel Pujol Busquets, Teresa Clavaguera Poch, M Cruz Fernández-Espartero, Loreto Carmona Ortell, Eduardo Collantes Estévez.   

Abstract

OBJECTIVE: To describe the differential characteristics by gender and time since disease onset in patients diagnosed with ankylosing spondylitis (AS) attending the Spanish rheumatology clinics, including those on the "Spanish Registry of spondyloarthritis" (REGISPONSER), as well as the diagnostic and therapeutic implications that this entails. PATIENTS AND METHODS: This is a transversal and observational study of 1514 patients with AS selected from 2367 spondyloarthritis cases included in REGISPONSER. For each patient, the demographics, epidemiology, geriatric, clinical, laboratory, radiological, and therapeutic aspects were were evaluated and comprehensively recorded under the aegis of REGISPONSER, constituting the Minimum Basic identifying data for the disease. Physical function was assessed by Bath Ankylosing Spondylitis Functional Index (BASFI). Clinical activity was evaluated using erythrocyte sedimentation rate, C reactive protein and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI). Each patient underwent pelvic anteroposterior, anteroposterior and lateral lumbar spine as well as lateral cervical spine x rays; they were scored according to the Bath Ankylosing Spondylitis Spine Radiographic Index, which measures structural damage.
RESULTS: Of the 1514 patients screened, 1131 (74.7%) were men. We found significant differences in age at onset of symptoms as well as in the day of inclusion, between the two groups, being lower in men. We also obtained differences in the duration of the disease, which was lower in women. As for the existence of a history of AS among first-degree relatives, family forms were more common among women. The mean BASDAI score was also higher in women, regardless of time since onset of disease. In contrast, the improvement of pain with the use of NSAID's and radiological severity were higher in men, both reaching statistical significance.
CONCLUSIONS: Among the Spanish AS patients, there are some differences in the clinical manifestations, even when the time since onset of disease was controlled; we also found radiological differences by gender; men showing more structural damage, while women were more active. These data suggest that the phenotype of AS differs between genders. This can influence the subsequent diagnostic approach and therapeutic decisions.
Copyright © 2011 Elsevier España, S.L. All rights reserved.

Entities:  

Keywords:  Ankylosing spondylitis; Bath Ankylosing Spondylitis Radiographic Index Spine; Clinical differences; Diferencias clínicas; Espondilitis anquilosante; REGISPONSER; Sex; Sexo

Mesh:

Year:  2013        PMID: 23474378     DOI: 10.1016/j.reuma.2012.09.008

Source DB:  PubMed          Journal:  Reumatol Clin        ISSN: 1699-258X


  8 in total

1.  Mortality in patients with ankylosing spondylitis in Argentina.

Authors:  Emilio Andres Buschiazzo; Emilce Edith Schneeberger; Fernando Andres Sommerfleck; Cesar Ledesma; Gustavo Citera
Journal:  Clin Rheumatol       Date:  2016-07-04       Impact factor: 2.980

2.  Ankylosing spondylitis risk factors: a systematic literature review.

Authors:  Mark C Hwang; Lauren Ridley; John D Reveille
Journal:  Clin Rheumatol       Date:  2021-03-22       Impact factor: 3.650

3.  Gender differences among patients with primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease in an iberoamerican spondyloarthritis cohort.

Authors:  Margarita Landi; Hernán Maldonado-Ficco; Rodolfo Perez-Alamino; José A Maldonado-Cocco; Gustavo Citera; Pablo Arturi; Percival D Sampaio-Barros; Diana E Flores Alvarado; Rubén Burgos-Vargas; Elena Santos; Daniel Palleiro; Miguel A Gutiérrez; Elsa Vieyra-Sousa; Fernando Pimentel-Santos; Sergio O Paira; Alberto Berman; Claudia Vera Barrezueta; Janitzia Vazquez-Mellado; Eduardo Collantes-Estevez
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

4.  The Importance of Sex Stratification in Autoimmune Disease Biomarker Research: A Systematic Review.

Authors:  Kristy Purnamawati; Jamie Ann-Hui Ong; Siddharth Deshpande; Warren Kok-Yong Tan; Nihar Masurkar; Jackson Kwee Low; Chester Lee Drum
Journal:  Front Immunol       Date:  2018-06-04       Impact factor: 7.561

5.  Differences between men and women with nonradiographic axial spondyloarthritis: clinical characteristics and treatment effectiveness in a real-life prospective cohort.

Authors:  Regula Neuenschwander; Monika Hebeisen; Raphael Micheroli; Kristina Bürki; Pascale Exer; Karin Niedermann; Michael J Nissen; Almut Scherer; Adrian Ciurea
Journal:  Arthritis Res Ther       Date:  2020-10-09       Impact factor: 5.156

6.  Estrogen attenuates the spondyloarthritis manifestations of the SKG arthritis model.

Authors:  Hyemin Jeong; Eun-Kyung Bae; Hunnyun Kim; Yeong Hee Eun; In Young Kim; Hyungjin Kim; Jaejoon Lee; Chan Hong Jeon; Eun-Mi Koh; Hoon-Suk Cha
Journal:  Arthritis Res Ther       Date:  2017-09-07       Impact factor: 5.156

Review 7.  Spotlight on certolizumab pegol in the treatment of axial spondyloarthritis: efficacy, safety and place in therapy.

Authors:  Josefina Marin; María Laura Acosta Felquer; Enrique R Soriano
Journal:  Open Access Rheumatol       Date:  2018-05-07

8.  Selective estrogen receptor modulator lasofoxifene suppresses spondyloarthritis manifestation and affects characteristics of gut microbiota in zymosan-induced SKG mice.

Authors:  Hyemin Jeong; In Young Kim; Eun-Kyung Bae; Chan Hong Jeon; Kwang-Sung Ahn; Hoon-Suk Cha
Journal:  Sci Rep       Date:  2021-06-07       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.